The cytotoxic activity of CD8+ T cells toward CT26 cancer cells was increased by sICAM‐1 (10.6%: from 12.0% to 22.6%), comparable to anti‐PD‐1's extent of stimulation (12.6%: from 12.0% to 24.6%). This evidence concerns the gene CD8A and cancer.